Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Intersect ENT Inc announces closing of initial public offering


Tuesday, 29 Jul 2014 04:05pm EDT 

Intersect ENT Inc:Closes initial public offering of 5,750,000 shares of its common stock at a public offering price of $11.00 per share, including 750,000 shares sold pursuant to the underwriters' option to purchase additional shares.Shares began trading on The NASDAQ Global Market on July 24, 2014 under the ticker symbol XENT.J.P. Morgan Securities LLC and Piper Jaffray & Co. acted as joint book-running managers for the offering.Leerink Partners and Wedbush PacGrow Life Sciences acted as co-managers. 

Company Quote

17.37
-0.23 -1.31%
21 Nov 2014